Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners

Page 1 of 2

Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund’s top picks for the first time. The fund had an equity portfolio valued at $207.76 million at the end of the year, which consisted of 27 long positions, and one put position, and $936.83 million in assets under management.


Great Point Partners was founded in 2003, and has a long history of investing in both public and private healthcare companies, providing them with the financing and insight needed to maximize their operations as well as shareholder value. The fund has invested more than $1 billion in more than 100 healthcare businesses since its inception. Great Point is also unique in that a bigger portion of the fund’s investment, 8%, comes from the fund’s own partners, compared to just 1% of a typical private equity firm’s investment. Thus the partners are just as invested in the company as its own investors are.

Great Point’s top pick is Connecture Inc (NASDAQ:CNXR), a new position for the fund in the fourth quarter, as the web-based platform of health insurance went public in December. Great Point was an investor in Connecture while the company was still private, recapitalizing them in August 2012 as Connecture was on the verge of drastically ramping up its services thanks to the implementation of the Affordable Care Act. Connecture CEO Doug Schneider described the partnership as invaluable.

“The Great Point team has the health care information technology and payer sector domain expertise to complement and support our strategic vision as a company. They were able to bring value immediately, most notably with the sourcing and execution of DRX on very favorable debt financing terms,” Schneider said.

Connecture Inc (NASDAQ:CNXR) priced its IPO of 6.64 million shares at $8.00 each, and shares are up just over 10% since, at $8.81 in afternoon trading Monday. Connecture releases its fourth quarter and full-year earnings results on March 10. Connecture was a popular stock among hedge funds we track, with 13 opening new positions between the IPO and the end of the year, though the majority of them were small. The largest such position after Great Point’s was that of Jeremy Green’s Redmile Group, which held 943,000 shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!